T<sub>1a</sub>期肾恶性肿瘤大小与预后不良病理特征的相关性研究

陈宇锋; 朱梁松; 王建丰; 孔文; 陈勇辉; 黄翼然; 薛蔚; 张进

doi:10.13201/j.issn.1001-1420.2019.07.013

T_1a期肾恶性肿瘤大小与预后不良病理特征的相关性研究

- 1. 上海交通大学医学院附属仁济医院泌尿科(上海, 200127);
- 2. 上海中医药大学附属普陀医院泌尿外科

详细信息

通讯作者: 张进,E-mail:med-zhangjin@vip.sina.com

中图分类号: R737.11

收稿日期: 2017-10-11

Correlation between tumor size and adverse histopathologic characteristics in patients with clinical T_1a renal cell carcinoma

- 1. Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China;
- 2. Department of Urology, Putuo Hospital of Shanghai University of Traditional Chinese Medicine

More Information

Corresponding author: ZHANG Jin, E-mail: med-zhangjin@vip.sina.com

Received Date: 11 October 2017

摘要

摘要: 目的：探讨T_1a期肾肿瘤大小与预后不良病理特征的关系。方法：回顾性分析2009年1月~2016年12月上海交通大学医学院附属仁济医院泌尿科（东院）收治的1 703例肿瘤直径<4cm的T_1a期肾肿瘤且病理确诊为肾细胞癌患者，排除良性病变。分析不同肿瘤大小与一些不良病理特征之间的关系，包括组织类型Fuhrman高级别、伴淋巴管浸润、伴坏死、伴肉瘤样变、Ⅱ型乳头状癌及高分期（≥pT₃）等。结果：1 703例肾细胞癌患者中男1 201例（70.5%），女502例（29.5%），中位年龄56（20~89）岁，平均肿瘤最大直径（2.7±0.9） cm。各种不良病理特征共发生197例（11.6%），<1cm 1例，1~2cm 11例，>2~3cm 78例，>3~4cm 107例，进一步发现肿瘤的大小与组织类型Fuhrman高级别（P<0.001）、伴组织坏死（P<0.001）、Ⅱ型乳头状癌（P=0.049）及T分期≥pT₃期（P=0.018）等明显相关。肿瘤大小与各项危险因素的相关性分析得出Fuhrman级别（r=0.287，P<0.001）、是否伴有组织坏死（r=0.130，P<0.001）、病理分级是否>T₃期（r=0.090，P<0.001）、是否伴有肉瘤样变（r=0.052，P=0.032）和Ⅱ型乳头状癌百分比（r=0.051，P=0.035）均有统计学意义。结论：T_1a期肾癌的肿瘤大小亦与一些预示不良的病理特征有显著相关性，直径≤2cm肿瘤的各种不良病理特征发生率较少，直径>2cm肿瘤直径越大，不良病理特征的发生率亦显著增加，危险程度明显提高。
- 肾肿瘤 /
- 大小 /
- 不良病理特征
Abstract: Objective: To evaluate the relationship between the tumor size of the T_1arenal tumor and the incidence of adverse pathologic features.Method: We retrospectively analyzed 1703renal cell carcinoma patients with tumor size less than 4cm in Renji hospital from January 2009to December 2016, and excluded the benign lesion.The relationship between tumor size and the undesirable pathological characteristics, including the high Fuhrman degree, lymphovascular invasion, histologic tumor necrosis, sarcomatoid features, papillary typeⅡhistology and advanced stage (≥ pT₃) was analyzed.Result: There were 1 703cases of renal cell carcinoma including 1 201 (70.5%) males and 502 (29.5%) females.Their median age was 56years old (range, 20-89), and the average tumor diameter was (2.7±0.9) cm.The number of all kinds of bad pathologic feature was 197 (11.6%), 1in<1cm group, 11in 1-2cm group, 78in>2-3cm group, and 107in>3-4cm group.Further studies showed that tumor size was significantly related with the high Fuhrman degree (P<0.001), histologic tumor necrosis (P<0.001), papillary with typeⅡhistology (P=0.049) and advanced stage (P=0.018).Spearman analysis also showed that the tumor size was significantly associated with the incidence of adverse pathologic features, such as Fuhrman degree (r=0.287, P<0.001), histologic tumor necrosis (r=0.130, P<0.001), advanced stage (r=0.090, P<0.001), sarcomatoid features (r=0.052, P=0.032), papillary typeⅡhistology (r=0.051, P=0.035).Conclusion: T_1arenal tumor size was significantly associated with some aggressive pathological characteristics.When the tumor is smaller than 2cm, the incidence of adverse pathologic features is limited.Conversely, the incidence increases when the tumor is larger than 2cm, which predicts a relative aggressive results.
- renal tumor /
- tumor size /
- adverse histopathologic characteristic

HTML全文

参考文献(12)

[1]	Gill I S, Aron M, Gervais D A, et al.Clinical practice.Small renal mass[J].N Engl J Med, 2010, 362 (7):624-634.
[2]	王胜锋, 张丽, 刘斌.64层螺旋CT对肾脏占位性病变的诊断价值研究[J].临床泌尿外科杂志, 2017, 32 (10):800-804.
[3]	Joice G A, Pierorazio P M, Allaf M E.Update on active surveillance for clinical T1 renal tumors[J].Curr Opin Urol, 2016, 26 (5):405-409.
[4]	Campbell S C, Novick A C, Belldegrun A, et al.Guideline for management of the clinical T1 renal mass[J].JUrol, 2009, 182 (4):1271-1279.
[5]	许晖阳, 莫承强, 王宗任, 等.机器人辅助腹腔镜下肾部分切除术的短期疗效分析 (附22例报告)[J].临床泌尿外科杂志, 2017, 32 (5):335-338, 343.
[6]	Lamb G W, Bromwich E J, Vasey P, et al.Management of renal masses in patients medically unsuitable for nephrectomy——natural history, complications, and outcome[J].Urology, 2004, 64 (5):909-913.
[7]	Violette P, Abourbih S, Szymanski K M, et al.Solitary solid renal mass:can we predict malignancy?[J].BJUInt, 2012, 110 (11Pt B):E548-E552.
[8]	Jeon H G, Lee S R, Kim K H, et al.Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4cm or less:prevalence and predictors in Korean patients[J].Urology, 2010, 76 (3):574-579.
[9]	李刚, 宋华林, 王超, 等.小肾癌的病理特点及其临床意义[J].中华泌尿外科杂志, 2015, 36 (5):325-328.
[10]	Yoo S, You D, Jeong I G, et al.Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1 arenal cell carcinoma:papillary vs.clear cell renal cell carcinoma[J].J Cancer Res Clin Oncol, 2017, 143 (9):1845-1851.
[11]	高明珠, 王进有, 张海梁, 等.乳头状肾癌的临床病理特征及其预后因素[J].中国癌症杂志, 2014, 24 (4):299-303.
[12]	Abdel-Rahman O.Impact of tumor size on the outcome of patients with small renal cell carcinoma[J].Expert Rev Anticancer Ther, 2017, 17 (8):769-773.